132 related articles for article (PubMed ID: 16037128)
1. Negative regulation of growth hormone receptor signaling.
Flores-Morales A; Greenhalgh CJ; Norstedt G; Rico-Bautista E
Mol Endocrinol; 2006 Feb; 20(2):241-53. PubMed ID: 16037128
[TBL] [Abstract][Full Text] [Related]
2. The SOCS2 ubiquitin ligase complex regulates growth hormone receptor levels.
Vesterlund M; Zadjali F; Persson T; Nielsen ML; Kessler BM; Norstedt G; Flores-Morales A
PLoS One; 2011; 6(9):e25358. PubMed ID: 21980433
[TBL] [Abstract][Full Text] [Related]
3. Role of the cytokine-induced SH2 domain-containing protein CIS in growth hormone receptor internalization.
Landsman T; Waxman DJ
J Biol Chem; 2005 Nov; 280(45):37471-80. PubMed ID: 16154995
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of the growth hormone-induced Janus kinase 2/signal transducer and activator of transcription 5 signaling pathway requires an intact actin cytoskeleton.
Rico-Bautista E; Negrín-Martínez C; Novoa-Mogollón J; Fernández-Perez L; Flores-Morales A
Exp Cell Res; 2004 Mar; 294(1):269-80. PubMed ID: 14980520
[TBL] [Abstract][Full Text] [Related]
5. Cytokine-inducible SH2 protein up-regulation is associated with desensitization of GH signaling in GHRH-transgenic mice.
González L; Miquet JG; Sotelo AI; Bartke A; Turyn D
Endocrinology; 2002 Feb; 143(2):386-94. PubMed ID: 11796490
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D3 cannot revert desensitization of growth hormone (GH)-induced STAT5-signaling in GH-overexpressing mice non-calcemic tissues.
Sotelo AI; Miquet JG; González L; Bartke A; Turyn D
Growth Horm IGF Res; 2008 Apr; 18(2):148-56. PubMed ID: 17881271
[TBL] [Abstract][Full Text] [Related]
7. Regulation of growth hormone signaling by selective estrogen receptor modulators occurs through suppression of protein tyrosine phosphatases.
Leung KC; Brce J; Doyle N; Lee HJ; Leong GM; Sjögren K; Ho KK
Endocrinology; 2007 May; 148(5):2417-23. PubMed ID: 17272397
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the role of β-TrCP in growth hormone transduction defect (GHTD).
Kostopoulou E; Rojas Gil AP; Spiliotis BE
Horm Mol Biol Clin Investig; 2020 Mar; 41(2):. PubMed ID: 32114520
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone signalling and its regulation: preventing too much of a good thing.
Frank SJ
Growth Horm IGF Res; 2001 Aug; 11(4):201-12. PubMed ID: 11735235
[TBL] [Abstract][Full Text] [Related]
11. Hepatic growth hormone resistance during sepsis is associated with increased suppressors of cytokine signaling expression and impaired growth hormone signaling.
Yumet G; Shumate ML; Bryant DP; Lang CH; Cooney RN
Crit Care Med; 2006 May; 34(5):1420-7. PubMed ID: 16540952
[TBL] [Abstract][Full Text] [Related]
12. Suppressor of cytokine signaling-2 deficiency induces molecular and metabolic changes that partially overlap with growth hormone-dependent effects.
Rico-Bautista E; Greenhalgh CJ; Tollet-Egnell P; Hilton DJ; Alexander WS; Norstedt G; Flores-Morales A
Mol Endocrinol; 2005 Mar; 19(3):781-93. PubMed ID: 15563548
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
Lincoln DT; Singal PK; Al-Banaw A
Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592
[TBL] [Abstract][Full Text] [Related]
14. [Growth hormone insensitivity of rats under the endotoxemic condition].
Wang P; Li N; Li J; Li W
Zhonghua Wai Ke Za Zhi; 2002 Dec; 40(12):940-4. PubMed ID: 12654216
[TBL] [Abstract][Full Text] [Related]
15. GHR signalling: Receptor activation and degradation mechanisms.
Chhabra Y; Lee CMM; Müller AF; Brooks AJ
Mol Cell Endocrinol; 2021 Jan; 520():111075. PubMed ID: 33181235
[TBL] [Abstract][Full Text] [Related]
16. Role of the growth hormone (GH) receptor transmembrane domain in receptor predimerization and GH-induced activation.
Yang N; Wang X; Jiang J; Frank SJ
Mol Endocrinol; 2007 Jul; 21(7):1642-55. PubMed ID: 17456794
[TBL] [Abstract][Full Text] [Related]
17. Alterations in growth hormone receptor abundance regulate growth hormone signaling in murine obstructive cholestasis.
Held MA; Cosme-Blanco W; Difedele LM; Bonkowski EL; Menon RK; Denson LA
Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G986-93. PubMed ID: 15604202
[TBL] [Abstract][Full Text] [Related]
18. Identification of protein tyrosine phosphatases with specificity for the ligand-activated growth hormone receptor.
Pasquali C; Curchod ML; Wälchli S; Espanel X; Guerrier M; Arigoni F; Strous G; Hooft van Huijsduijnen R
Mol Endocrinol; 2003 Nov; 17(11):2228-39. PubMed ID: 12907755
[TBL] [Abstract][Full Text] [Related]
19. Clinical review 112: Does serum growth hormone (GH) binding protein reflect human GH receptor function?
Amit T; Youdim MB; Hochberg Z
J Clin Endocrinol Metab; 2000 Mar; 85(3):927-32. PubMed ID: 10720017
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone and prolactin receptors in adipogenesis: STAT-5 activation, suppressors of cytokine signaling, and regulation of insulin-like growth factor I.
Fleenor D; Arumugam R; Freemark M
Horm Res; 2006; 66(3):101-10. PubMed ID: 16735796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
